Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd. on January 14, 2020, for the month of January 2020. The filing serves to furnish materials related to an extraordinary general meeting of shareholders scheduled for February 18, 2020, at the company's offices in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing containing notices and proxy materials rather than a financial report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The document focuses solely on the logistics and documentation for the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It incorporates by reference the Notice and Proxy Statement (Exhibit 99.1) and Proxy Card (Exhibit 99.2) for the extraordinary general meeting.
Key Facts for Investors to Verify
- The date, time, and location of the extraordinary general meeting of shareholders.
- The specific proposals to be voted on, as detailed in the incorporated Notice and Proxy Statement (Exhibit 99.1).
- Whether the company has filed its annual report under Form 20-F (indicated as yes in this filing).
- The identity of the authorized signatory, Adam Gridley, Chief Executive Officer.